Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Create Stock SIPAutomate your investments in this
Performance
Open
356.95Prev. Close
356.20Volume
3,050Total traded value
0.11 CrUpper Circuit
427.40Lower Circuit
285.00Fundamentals
| Market Cap | ₹627Cr |
| ROE | 10.38% |
| P/E Ratio(TTM) | 23.99 |
| EPS(TTM) | 14.95 |
| P/B Ratio | 2.36 |
| Dividend Yield | 0.00% |
| Industry P/E | 33.43 |
| Book Value | 151.97 |
| Debt to Equity | 0.31 |
| Face Value | 10 |
Understand Fundamentals
Financials
About Kilitch Drugs (india) Limited.
Kilitch Drugs is a leading pharmaceutical company that manufactures and markets a wide range of formulations like tablets, liquids, and injectables across the globe. The company is driven by a profound purpose to contribute to global health through its quality products, customers, and partners worldwide. It operates the largest Cephalosporin plant in East Africa, producing various dosage forms for African markets.;
| Parent Organisation | Kilitch Drugs (india) Limited. |
| Managing Director | Mr. Mukund Mehta |
| NSE Symbol | KILITCH |
Shareholding Pattern
Sep '24
Dec '24
Mar '25
Jun '25
Sep '25
Similar Stocks
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Torrent Pharmaceuticals | NA (0.00%) | 60.36 | ||
| Ajanta Pharma | NA (0.00%) | 32.12 | ||
| Gland Pharma | NA (0.00%) | 37.83 | ||
| Eris Lifesciences | NA (0.00%) | 47.50 |